IndiaTickerKabra Drugs Ltd - 524322 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018BSE · exchange filing · pdf
Source filing Company dossier
Kabra Drugs
BSE:KABRADG · ISIN INE323K01017
- Close
- Unavailable Date unavailable
- Daily change
- N/A Exchange close
- Evidence state
- Building 0/0 checks
Kabra Drugs
Filings
Preserved evidence
40 recent eventsPrimary-source filing timeline
Kabra Drugs Ltd - 524322 - Announcement under Regulation 30 (LODR)-Change of Company NameBSE · exchange filing · pdf
Source filing Kabra Drugs Ltd - 524322 - Closure of Trading WindowBSE · exchange filing · pdf
Source filing Kabra Drugs Ltd - 524322 - Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseBSE · exchange filing · pdf
Source filing Kabra Drugs Ltd - 524322 - Receipt Of Letter Of Intent From Chhattisgarh Government For Proposed Investment Of ?200 Crore In Pharmaceutical Manufacturing Project At Nava Raipur Pharma ParkBSE · exchange filing · pdf
Source filing Kabra Drugs Ltd - 524322 - Revised Receipt Of Letter Of Intent From Chhattisgarh Government For Proposed Investment Of Rs. 200 Crore In Pharmaceutical Manufacturing Project At Nava Raipur Pharma ParkBSE · exchange filing · pdf
Source filing Kabra Drugs Ltd - 524322 - Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportBSE · exchange filing · pdf
Source filing Kabra Drugs Ltd - 524322 - Shareholder Meeting / Postal Ballot-Outcome of Postal_BallotBSE · exchange filing · pdf
Source filing Kabra Drugs Ltd - 524322 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE · exchange filing · pdf
Source filing Kabra Drugs Ltd - 524322 - Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseBSE · financial results · pdf
Source filing Kabra Drugs Ltd - 524322 - Financial Results For Quarterly & Year Ended 31St March 2026.BSE · financial results · pdf
Source filing Kabra Drugs Ltd - 524322 - Undertaking For Non- Applicability Of Regulation 32 Of SEBI (LODR) Regulations, 2015 For The Quarter Ended On 31St March 2026.BSE · exchange filing · pdf
Source filing Kabra Drugs Ltd - 524322 - Board Meeting Outcome for Outcome Of Board Meeting Held On 29Th May 2026BSE · exchange filing · pdf
Source filing Kabra Drugs Ltd - 524322 - Board Meeting Outcome for Outcome Of Board Meeting Held On 29Th May 2026BSE · exchange filing · pdf
Source filing Kabra Drugs Ltd - 524322 - Board Meeting Intimation for Intimation Of Board Meeting To Be Held On 29Th May 2026BSE · exchange filing · pdf
Source filing Kabra Drugs Ltd - 524322 - Compliances-Reg.24(A)-Annual Secretarial ComplianceBSE · exchange filing · pdf
Source filing Kabra Drugs Ltd - 524322 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE · exchange filing · pdf
Source filing Kabra Drugs Ltd - 524322 - Shareholder Meeting / Postal Ballot-Notice of Postal BallotBSE · exchange filing · pdf
Source filing Kabra Drugs Ltd - 524322 - Board Meeting Outcome for Outcome Of Board Meeting Held On 06Th May 2026BSE · exchange filing · pdf
Source filing Kabra Drugs Ltd - 524322 - Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseBSE · exchange filing · pdf
Source filing Kabra Drugs Ltd - 524322 - Board Meeting Intimation for Intimation Of Board Meeting To Be Held On 06Th May 2026BSE · exchange filing · pdf
Source filing Kabra Drugs Ltd - 524322 - Announcement under Regulation 30 (LODR)-Change in DirectorateBSE · exchange filing · pdf
Source filing Kabra Drugs Ltd - 524322 - Board Meeting Outcome for Outcome Of Board Meeting Held On 21St April 2026BSE · exchange filing · pdf
Source filing Kabra Drugs Ltd - 524322 - Board Meeting Intimation for Intimation Of Board Meeting To Be Held On 21-April-2026BSE · exchange filing · pdf
Source filing Kabra Drugs Ltd - 524322 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018BSE · exchange filing · pdf
Source filing Kabra Drugs Ltd - 524322 - Closure of Trading WindowBSE · exchange filing · pdf
Source filing Kabra Drugs Ltd - 524322 - Board Meeting Outcome for Outcome Of Board Meeting Held On 07 Th March 2026, As Per Regulation 30 Of SEBI
(Listing Obligations And Disclosure Requirements) Regulations, 2015.BSE · exchange filing · pdf
Source filing Kabra Drugs Ltd - 524322 - Board Meeting Intimation for Intimation Of Board Meeting To Be Held On March 7, 2026BSE · exchange filing · pdf
Source filing Kabra Drugs Ltd - 524322 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE · financial results · pdf
Source filing Kabra Drugs Ltd - 524322 - Financial Results For The Quarter Ended 31St December 2025 Under Regulation 33 Of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015BSE · financial results · pdf
Source filing Kabra Drugs Ltd - 524322 - Board Meeting Outcome for Outcome Of Board Meeting Held On 13Th February 2026, As Per Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.BSE · exchange filing · pdf
Source filing Kabra Drugs Ltd - 524322 - Undertaking For Non- Applicability Of Regulation 32 Of SEBI (LODR) Regulations, 2015 For The Quarter Ended On 31St December 2025.BSE · exchange filing · pdf
Source filing Kabra Drugs Ltd - 524322 - Board Meeting Intimation for Intimation Of Board MeetingBSE · exchange filing · pdf
Source filing Kabra Drugs Ltd - 524322 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018BSE · exchange filing · pdf
Source filing Kabra Drugs Ltd - 524322 - Board Meeting Outcome for Board Meeting Outcome For Outcome Of Board Meeting Held On 01St January 2026, As Per Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.BSE · exchange filing · pdf
Source filing Kabra Drugs Ltd - 524322 - Closure of Trading WindowBSE · exchange filing · pdf
Source filing Kabra Drugs Ltd - 524322 - Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportBSE · exchange filing · pdf
Source filing Kabra Drugs Ltd - 524322 - Shareholder Meeting / Postal Ballot-Outcome of EGMBSE · exchange filing · pdf
Source filing Kabra Drugs Ltd - 524322 - Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015BSE · exchange filing · pdf
Source filing Kabra Drugs Ltd - 524322 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE · exchange filing · pdf
Source filing